Withdrawal of Approval of Drug Application: Acrotech Biopharma, LLC; MARQIBO (VinCRIStine Sulfate LIPOSOME Injection), 5 milligrams/5 milliliters

TitleWithdrawal of Approval of Drug Application: Acrotech Biopharma, LLC; MARQIBO (VinCRIStine Sulfate LIPOSOME Injection), 5 milligrams/5 milliliters
ToC Doc Acrotech Biopharma, LLC; MARQIBO (VinCRIStine Sulfate LIPOSOME Injection), 5 milligrams/5 milliliters
Docket Number2022-09235
Type Notice
Subject Withdrawal of Approval of Drug Application:
Acrotech Biopharma, LLC; MARQIBO (VinCRIStine Sulfate LIPOSOME Injection), 5 milligrams/5 milliliters
Publication Date2022-05-02
Last Updated Date 2022-04-29 08:15:08 -0400
Last Public Inspection2022-04-29
Filed At2022-04-29T08:45:00.000-04:00
PDF 2022-09235_PI.pdf (93690 bytes)
Download TXT / HTML / JSON
Number of Pages 3
Filing Typeregular
AgenciesFood and Drug Administration

You can find the raw source document below...

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied. OFR.report is not affiliated with the Office of the Federal Register or the US government in any way.

© OFR.report 2021